Supplier
Caremark, L.L.C.
Caremark, L.L.C. was paid $34.08M by Medicaid between Jan 2018 and Oct 2024, across 30 billing codes. Its largest line is 90378, — 25% of everything it billed.
33Billing provider infoCAREMARK, L.L.C.
MT PROSPECT, IL 60056
MT PROSPECT, IL 60056
33aNPI1134100134assigned 11/08/2005
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$34.08M
24GClaims22,664
24DCodes billed30
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Illinois
Rank by total paid#6 of 323
Median peer was paid$217K
This provider vs. median157×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official AYCOCK, BRANDON controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,742 | $11.63M | |
| 2019 | 6,751 | $11.33M | |
| 2020 | 2,552 | $3.46M | |
| 2021 | 2,445 | $3.38M | |
| 2022 | 2,816 | $2.79M | |
| 2023 | 1,850 | $1.10M | |
| 2024incomplete | 508 | $391K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90378 | 25% | 3,057 | 2,241 | $8.39M | |
| J2357 | Injection, omalizumab, 5 mg | 20% | 2,782 | 2,100 | $6.83M |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | 11% | 1,674 | 1,100 | $3.77M |
| J3285 | Injection, treprostinil, 1 mg | 10% | 1,906 | 832 | $3.52M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 7.5% | 2,617 | 2,570 | $2.57M |
| J3357 | Ustekinumab, for subcutaneous injection, 1 mg | 6.2% | 154 | 129 | $2.12M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 4.8% | 2,055 | 1,662 | $1.64M |
| J2182 | Injection, mepolizumab, 1 mg | 3.8% | 446 | 406 | $1.28M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 3.3% | 971 | 918 | $1.14M |
| J1559 | Injection, immune globulin (hizentra), 100 mg | 2.8% | 390 | 226 | $959K |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 1.5% | 197 | 178 | $504K |
| J0517 | Injection, benralizumab, 1 mg | 1.3% | 103 | 100 | $458K |
18 more codes
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | 1.2% | 1,580 | $400K |
| 99601 | <1% | 755 | $155K | |
| J3590 | Unclassified biologics | <1% | 30 | $70K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 153 | $56K |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 59 | $51K |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | <1% | 37 | $36K |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | <1% | 35 | $31K |
| 99602 | Nursing care in home rn | <1% | 117 | $26K |
| J3490 | Unclassified drugs | <1% | 82 | $25K |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 1,244 | $19K |
| K0455 | Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol) | <1% | 529 | $14K |
| S9379 | Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 77 | $3K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | <1% | 620 | $3K |
| J7518 | Mycophenolic acid, oral, 180 mg | <1% | 56 | $2K |
| E0781 | Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient | <1% | 108 | $2K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | <1% | 769 | $878.72 |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | <1% | 45 | $145.13 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 16 | $10.08 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAYCOCK, BRANDON (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Procare Pharmacy Direct, LLC. | Monroeville, PA | $227.31M |
| Procare Pharmacy, L.L.C. | Honolulu, HI | $41.83M |
| Caremark, L.L.C. | Redlands, CA | $19.87M |
| Caremark, L.L.C. | Tampa, FL | $7.28M |
| Caremark, L.L.C. | Fairfield, NJ | $3.43M |
| Caremark L.L.C. | Raleigh, NC | $2.69M |
| Caremark L.L.C. | Lenexa, KS | $2.54M |
| Caremark, L.L.C. | Milford, MA | $2.20M |
| Caremark, L.L.C. | Bartlett, TN | $1.96M |
| Procare Pharmacy, LLC. | Birmingham, AL | $623K |
| Procare Pharmacy, L.L.C. | Portland, ME | $109K |
| Procare Pharmacy LLC | Boston, MA | $724.47 |
| Caremark, LLC | Mt. Prospec, IL | $76.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.